CN102605076B - 指导华法林使用起始剂量快速基因分型的方法和试剂盒 - Google Patents
指导华法林使用起始剂量快速基因分型的方法和试剂盒 Download PDFInfo
- Publication number
- CN102605076B CN102605076B CN201210082350.8A CN201210082350A CN102605076B CN 102605076 B CN102605076 B CN 102605076B CN 201210082350 A CN201210082350 A CN 201210082350A CN 102605076 B CN102605076 B CN 102605076B
- Authority
- CN
- China
- Prior art keywords
- warfarin
- quick
- cyp2c9
- gene
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 title claims abstract description 27
- 229960005080 warfarin Drugs 0.000 title claims abstract description 27
- 238000003205 genotyping method Methods 0.000 title abstract description 7
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 29
- 238000012360 testing method Methods 0.000 claims description 15
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- 239000000975 dye Substances 0.000 claims description 3
- 238000013016 damping Methods 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 239000003643 water by type Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 25
- 108010000543 Cytochrome P-450 CYP2C9 Proteins 0.000 abstract description 24
- 102000002269 Cytochrome P-450 CYP2C9 Human genes 0.000 abstract description 24
- 108020004414 DNA Proteins 0.000 abstract description 9
- 238000001514 detection method Methods 0.000 abstract description 7
- 238000005516 engineering process Methods 0.000 abstract description 6
- 102000053602 DNA Human genes 0.000 abstract description 3
- 238000003745 diagnosis Methods 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 230000002265 prevention Effects 0.000 abstract description 2
- 230000001732 thrombotic effect Effects 0.000 abstract description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
- 238000002844 melting Methods 0.000 description 20
- 230000008018 melting Effects 0.000 description 20
- 239000000523 sample Substances 0.000 description 9
- 230000004304 visual acuity Effects 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000012408 PCR amplification Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000007704 transition Effects 0.000 description 4
- 108090000779 Vitamin K Epoxide Reductases Proteins 0.000 description 3
- 102000004210 Vitamin K Epoxide Reductases Human genes 0.000 description 3
- 230000000869 mutational effect Effects 0.000 description 3
- 102000054765 polymorphisms of proteins Human genes 0.000 description 3
- 206010071602 Genetic polymorphism Diseases 0.000 description 2
- 230000010100 anticoagulation Effects 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 101150053096 CYP2C9 gene Proteins 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000006193 Pulmonary infarction Diseases 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 108010064129 Thrombogen Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 101150025072 VKORC1 gene Proteins 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 239000003596 drug target Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000011880 melting curve analysis Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000002974 pharmacogenomic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000007575 pulmonary infarction Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210082350.8A CN102605076B (zh) | 2012-03-26 | 2012-03-26 | 指导华法林使用起始剂量快速基因分型的方法和试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210082350.8A CN102605076B (zh) | 2012-03-26 | 2012-03-26 | 指导华法林使用起始剂量快速基因分型的方法和试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102605076A CN102605076A (zh) | 2012-07-25 |
CN102605076B true CN102605076B (zh) | 2014-02-19 |
Family
ID=46522840
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210082350.8A Active CN102605076B (zh) | 2012-03-26 | 2012-03-26 | 指导华法林使用起始剂量快速基因分型的方法和试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102605076B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103525911A (zh) * | 2013-09-22 | 2014-01-22 | 上海中优医药高科技有限公司 | 利用高分辨熔解曲线分析技术检测华法林个体化用药相关基因多态性的方法 |
CN105671152A (zh) * | 2016-02-06 | 2016-06-15 | 厦门大学附属中山医院 | 一种基于AllGlo探针的VKORC1基因多态性检测分型试剂盒及其分型方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101886117A (zh) * | 2009-05-13 | 2010-11-17 | 世基生物医学股份有限公司 | 用以鉴别目标核酸的单核苷酸多态性的检验套组 |
CN102268476B (zh) * | 2010-06-01 | 2014-02-19 | 爱科来株式会社 | Vkorc1基因的第-1639位碱基的多态性检测方法、以及用于该方法的核酸探针和试剂盒 |
CN102251043A (zh) * | 2011-07-27 | 2011-11-23 | 协和干细胞基因工程有限公司 | 检测华法林个体化用药相关snp位点的试剂盒及其多重pcr扩增方法和检测方法 |
-
2012
- 2012-03-26 CN CN201210082350.8A patent/CN102605076B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN102605076A (zh) | 2012-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103146692A (zh) | 一种用于快速检测华法林个体化用药相关基因snp位点的试剂盒及其检测方法 | |
Lie et al. | A lateral flow biosensor for detection of nucleic acids with high sensitivity and selectivity | |
CN102433376B (zh) | 基于荧光淬灭的基因变异检测方法及探针 | |
CN104232781A (zh) | 一种检测HLA-B*5801等位基因的TaqMan探针实时荧光PCR方法 | |
CN105274190A (zh) | 一种检测cyp3a4*1g和mdr1c1236t的基因多态性的hrm方法 | |
CN102925562A (zh) | 氨基糖苷类药物性耳聋易感基因检测试剂盒及方法 | |
CN103757091A (zh) | 心源性猝死快速基因检测试剂盒及检测方法 | |
CN102732633B (zh) | 人idh基因突变的检测引物和试剂盒 | |
CN104561301A (zh) | Cyp2c9*3基因多态性的检测方法以及该方法的核酸探针和试剂盒 | |
CN104561300A (zh) | Cyp2c9*2基因多态性的检测方法以及该方法的核酸探针和试剂盒 | |
CN104293932B (zh) | 一种基于实时荧光pcr检测hla‑b*5801等位基因的方法 | |
CN102605076B (zh) | 指导华法林使用起始剂量快速基因分型的方法和试剂盒 | |
CN103276091A (zh) | 一种检测hiv前病毒dna的试剂盒 | |
CN105274228A (zh) | 一种华法林药物基因突变位点检测的试剂盒及检测方法 | |
CN107653317A (zh) | 一种分子信标探针检测人类cyp2c9基因多态性的试剂盒、方法及其应用 | |
CN102154445A (zh) | 一种预测冠心病易感性的方法及其试剂盒 | |
JP2021090390A (ja) | 脳梗塞のリスク評価方法 | |
CN104087671A (zh) | 一种用于检测人21号染色体数目的试剂盒 | |
CN105506068A (zh) | 一种用于MMP2基因分型的ARMS-qPCR检测试剂盒及检测方法 | |
CN105506067A (zh) | 一种用于NOSLAP基因分型的ARMS-qPCR检测试剂盒及检测方法 | |
CN102329885B (zh) | 一种用于检测vkorc1和cyp2c9基因多态性的试剂盒 | |
Zhang et al. | A point-of-care single nucleotide variation assay based on strand-displacement-triggered recombinase polymerase amplification | |
CN104073548A (zh) | 基于溶解曲线的单核苷酸多态性检测方法及其试剂盒 | |
CN105969842A (zh) | 基于AllGlo探针的Glu504lys检测分型试剂盒及其分型方法 | |
CN103290111B (zh) | 基于dna自组装的非酶snp检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: ZHUHAI SINOCHIPS BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: WANG DAOWEN Effective date: 20150619 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150619 Address after: 519000 Guangdong, Zhuhai Jin Jin Feng West Road, No. 2, building 4, floor 24 Patentee after: Zhuhai Sinochips Biotechnology Co., Ltd. Address before: 6, building 2, building 303, 1095 Jiefang Avenue, Hankou, Hubei, Wuhan 430030, China Patentee before: Wang Daowen |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 519000 Guangdong City, Zhuhai Province, the town of Tang Feng Feng West Road, No. 2, building 4, floor 24 Patentee after: ZHUHAI SINOCHIPS BIOTECHNOLOGY CO., LTD. Address before: 519000 Guangdong, Zhuhai Jin Jin Feng West Road, No. 2, building 4, floor 24 Patentee before: Zhuhai Sinochips Biotechnology Co., Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20220125 Address after: 519000 4th floor, building 2, No.24 Jinfeng West Road, Tangjiawan Town, Zhuhai City, Guangdong Province Patentee after: Zhuhai saileqi medical laboratory Co.,Ltd. Address before: 4 / F, building 2, No. 24, Jinfeng West Road, Tangjiawan Town, Zhuhai Patentee before: ZHUHAI SINOCHIPS BIOTECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |